Create your account

Analyse episodes, create alerts, spot trends before they go mainstream

Already have an account? Sign in

Companies

Hologen

Mentioned in 1 analyzed podcast episode across 1 show

Episode Mentions

How I Invest with David Weisburd

How I Invest with David Weisburd · Apr 22, 2026

E353: Why Biotech Is Struggling in Today’s Market (and the Future of Healthcare)

Portfolio company using AI and longitudinal patient data to optimize clinical trial design; brought Parkinson's asset to phase 3 with single-trial FDA approval.

Biotech Drug Development EconomicsInflation Reduction Act Impact on Pharma PricingChina's Dominance in Drug Discovery
View Analysis